Lamotrigine Tablet, Film Coated, Extended Release
Product Images NDC 10370-207

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 10370-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular-structure (Lamotrigine Extended Release Tablets 1)

Chemical structure of lamotrigine, showing the molecular arrangement including chlorinated phenyl and triazine rings with amino groups, consistent with the generic active ingredient name in Lamotrigine Extended-Release tablets.*

FDA Label Image

Figure 1 (Lamotrigine Extended Release Tablets 2)

A cumulative response rate graph comparing Lamotrigine Extended-Release Tablets (N=70) with placebo (N=73). The x-axis shows the percent of patients from 100% to 0%, and the y-axis displays responder rate from worsening (-100%) to improvement (100%). The graph illustrates higher responder rates for Lamotrigine Extended-Release compared to placebo.*

FDA Label Image

Figure-2 (Lamotrigine Extended Release Tablets 3)

A cumulative responder rate graph comparing Lamotrigine Extended-Release Tablets (N=116) to placebo (N=120). The y-axis shows responder rate from worsening to improvement, and the x-axis shows percent of patients. Two lines represent response rates for the drug and placebo groups across the patient population.*

FDA Label Image

Lamo Tabs (Lamotrigine Extended Release Tablets 4)

Illustration showing Lamotrigine Extended-Release tablets in four strengths: 100 mg (orange with speckles, round, imprint A207), 200 mg (blue with speckles, round, imprint A208), 250 mg (white to off-white with speckles, round, imprint A334), and 300 mg (gray with speckles, oval, imprint A256). Each tablet is film coated with imprint on one side and plain on the other.*

FDA Label Image

100 mg 30s (Lamotrigine Extended Release Tablets 5)

Label for Lamotrigine Extended-Release Tablets 100 mg by Par Health USA, LLC. The label states the product is oral, film-coated extended-release tablets, 30 count. It includes storage instructions (20° to 25°C), a barcode, manufacturer info, and pharmacist dispensing cautions.*

FDA Label Image

200 mg 30s (Lamotrigine Extended Release Tablets 6)

Label for Lamotrigine Extended-Release Tablets 200 mg, film-coated extended-release oral tablets, in a package of 30 tablets. The label shows the product is once-a-day dosing, Rx only, manufactured for Endo USA, and includes storage instructions and a barcode. The labeler is Par Health USA, LLC.*

FDA Label Image

250 mg 30s (Lamotrigine Extended Release Tablets 7)

Label for Lamotrigine Extended-Release Tablets 250 mg, a film-coated oral tablet. The package contains 30 tablets, labeled for once-a-day use and Rx only. Manufactured for Endo USA in Malvern, PA, and made in India. Includes pharmacist instruction to dispense the accompanying Medication Guide and storage conditions.*

FDA Label Image

300 mg 30s (Lamotrigine Extended Release Tablets 8)

Drug facts label for Lamotrigine Extended-Release Tablets 300 mg. It instructs pharmacists to dispense the Medication Guide and verify the product. The label notes the dosage form as extended-release film-coated tablets with a strength of 300 mg lamotrigine each. Storage instructions specify 20 to 25°C (68 to 77°F), with dispensing caution and safety seal warnings. Manufactured for Endo USA, Malvern, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.